What is the recommended daily dose of folic acid (folate) in a prenatal vitamin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Folic Acid Dosing in Prenatal Vitamins

Women at average risk should take 400-800 μg (0.4-0.8 mg) of folic acid daily in their prenatal vitamin, starting at least one month before conception and continuing throughout pregnancy. 1

Standard Dosing for Average-Risk Women

  • Take 400-800 μg daily starting at least one month before conception and continuing through the first 12 weeks of pregnancy for maximal neural tube defect prevention, as neural tube closure occurs within the first 28 days after conception, often before a woman knows she is pregnant. 1

  • After 12 weeks gestation, continue 400 μg (0.4 mg) daily throughout the remainder of pregnancy to meet fetal growth and developmental needs, even though this dose is no longer required specifically for neural tube protection. 1

  • This universal recommendation exists because approximately 50% of pregnancies in the United States are unplanned, making preconceptional supplementation essential for all women capable of becoming pregnant. 1

  • The US Preventive Services Task Force concluded with high certainty that the net benefit of folic acid supplementation at 400-800 μg daily is substantial, with inadequate evidence for any potential harm to mother or baby at this dose. 1

High-Risk Women Require Dramatically Different Dosing

High-risk women require 4,000 μg (4 mg) daily—a 10-fold higher dose than standard supplementation. 1

Who Is High-Risk?

High-risk status includes women with: 1, 2

  • Prior pregnancy affected by a neural tube defect
  • Personal history of neural tube defect
  • First-degree relative with neural tube defect
  • Type 1 diabetes mellitus
  • Taking high-risk medications during early pregnancy

High-Risk Dosing Protocol

  • Start 4,000 μg (4 mg) daily at least 3 months (12 weeks) before conception, which is earlier than the standard recommendation and reflects the need for adequate tissue saturation. 1, 2

  • Continue 4,000 μg (4 mg) daily through the first 12 weeks of gestation until completion of major organ development. 1, 2

  • After 12 weeks gestation, reduce to 400 μg (0.4 mg) daily for the remainder of pregnancy—this dose reduction is crucial to decrease potential health consequences of long-term high-dose ingestion, particularly masking vitamin B12 deficiency-related neurological symptoms. 1, 2

  • The 4 mg dose for high-risk women is based on the landmark British MRC Vitamin Study, which demonstrated that high-dose folic acid supplementation prevents recurrence of neural tube defects. 1, 2

Critical Safety Considerations

  • Total daily folate consumption should not exceed 1,000 μg (1 mg) unless prescribed by a physician, specifically to avoid masking vitamin B12 deficiency, which could lead to irreversible neurologic damage if not diagnosed and treated. 1, 3

  • Always rule out vitamin B12 deficiency before initiating high-dose folic acid supplementation, as folate can correct the hematologic manifestations of B12 deficiency while allowing neurological damage to progress. 1

  • Folic acid should be taken in a multivitamin including 2.6 μg/day of vitamin B12 to mitigate even theoretical concerns about masking B12 deficiency. 4

Common Pitfalls to Avoid

  • Do not prescribe 4 mg to average-risk women—this provides no additional benefit and increases the risk of masking B12 deficiency. 1 A Cochrane meta-analysis confirmed that higher doses of folate supplementation (>400 μg) in average-risk women do not provide additional benefit for preventing neural tube defects or other birth defects. 1

  • Do not stop supplementation after 12 weeks in average-risk women—continue 400 μg daily throughout pregnancy for fetal growth needs. 1

  • Do not continue 4 mg beyond 12 weeks gestation in high-risk women—reduce to 400 μg to minimize long-term high-dose risks. 1, 2

  • Women at high risk taking a multivitamin tablet containing folic acid should not take more than 1 daily dose of the multivitamin supplement; additional tablets containing only folic acid should be taken to achieve the desired 4 mg dose. 4

Practical Implementation

  • Folic acid supplementation should be combined with a healthy folate-rich diet, though supplementation is needed to achieve the red blood cell folate levels associated with maximal protection against neural tube defects. 4

  • In Canada and the US, multivitamin tablets with folic acid are usually available in 3 formats: regular over-the-counter multivitamins with 0.4-0.6 mg folic acid, prenatal over-the-counter multivitamins with 1.0 mg folic acid, and prescription multivitamins with 5.0 mg folic acid. 4

References

Guideline

Folic Acid Supplementation Guidelines for Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Folic Acid Supplementation for Neural Tube Defect Prevention

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Folic Acid Safety and Dosage Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Pre-conception Folic Acid and Multivitamin Supplementation for the Primary and Secondary Prevention of Neural Tube Defects and Other Folic Acid-Sensitive Congenital Anomalies.

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.